Percutaneous implantation of a new intracoronary stent in pigs
Intravascular expanding devices (stents) are proposed to support the dissected intimal wall after percutaneous transluminal coronary angioplasty (PT-CA).l Restenosis after PTCA, which occurs in at least 30 % of native coronary arteries2-4 and in at least 50 9; of venous bypass grafts5 might also be prevented by stent placement.
Plastic materials like Dacron and polytetrafluoroethylene* have been implanted successfully in biliary and urinary tracts. 6 These and other nonporous plastic materials were also used in peripheral arteries. However, implantation of such materials resulted From in a very high occlusion percentage due to thrombosis. The clinical experience with metal devices is clearly better. Dotter, 7 Cragg et al., s and Sugita and Shimomitsug implanted a coil spring of Nitinol, an alloy of nickel and titanium, which has a thermal shape memory. Nitinol stents are difficult to handle, because they tend to expand prematurely while in the guiding catheter.' Stainless steel stents are used by most other investigators;l% l"-16; however, clinical experience in coronary arteries is still limited.
Thrombus formation and restenosis have been documented as drawbacks in the use of presently available stents.17) l8 We studied a new stainless steel stent, developed by Medtronic Inc. (Minneapolis, Minn.) and the Rouen group (Letac, Cribier), as shown in Fig. 1 . This self-expanding parallel wire stent can be implanted percutaneously. In comparison with some of the other stents, the important improvement of this stent might be the relatively low amount of metal making up the endothelium when the stent is expanded. l8 This study presents the results of stent implantation in the coronary arteries of healthy pigs, with a documented follow-up from several hours to 6 months. Fig. 1 . A, This panel shows the parallel wire self-expanding stainless steel stent and its delivery system, consisting of a polyethylene inner and a Teflon outer catheter. The inner catheter has a tip marker. The system can be introduced over an 0.014 inch floppy guide wire. B, Schematic drawing of the release of the stent. Before implantation, the stent is compressed and loaded in the distal end of the outer catheter. After introduction of the system in the target vessel, the inner catheter is advanced until it abuts against the stent. Then the stent is freed by withdrawing the outer catheter while the inner catheter is held stationary.
METHODS
Animal preparation.
Twenty-nine landrace pigs (31 to 68 kg, 8 to 22 weeks of age) and two Giittingen minipigs (56 and 66 kg with an age of 78 and 80 weeks, respectively) were anesthetized with thiopental sodium (Nesdonal, Specia, Paris, France) (8 mg/kg intravenously) after pretreatment with azaperone (Stresnil, Janssen Pharmaceutics, Beerse, Belgium) (10 mg/kg intramuscularly). Subsequently, the animals were intubated and ventilated with 1% halothane, nitrous oxide, and oxygen. A femoral or carotid artery cutdown was performed allowing the introduction of an 8F guiding catheter (Interventional Medical, Danvers, Mass., or Schneider Medintag, Zurich, Switzerland, large lumen This relation is linear in the range that is clinically important-the partially compressed to noncompressed range. Data are given for 3.5, 4.0, and 4.5 mm stents.
Heparin (100 IV/kg intravenously) was given to all animals. After occurrence of spasm in the first two experiments, intracoronary nitroglycerin was routinely injected after the first coronary angiography. Dextran and aspirin were not administered. The stent was introduced into the target coronary artery using a specially developed delivery system ( Fig. 1, A) . Thereafter the stent (Fig. 1, B ) was released at a previously determined site, followed by repeat angiography. A preimplantation PTCA was not performed. Also postimplantation PTCA was not done because of the selfexpanding nature of the stent.
After stent implantation, ampicillin (1000 mg intravenously and 1000 mg intramuscularly) was administered. No further anticoagulant or antiplatelet therapy was applied after the initial heparin dose. Fluoroscopy was performed the day after implantation and coronary angiography was repeated at 1 week and before the animals were put to death. Following the last angiography, the animal was put to death by injecting (Euthasaat, pentobarbital sodium (200 mg/kg intravenously). Animals were killed in the short term at 1, 3, or 8 weeks, or after 6 months. The heart was excised and the coronary artery size was maintained under internal pressure of approximately 100 mm Hg by perfusion with glutaraldehyde, 2.5%, to preserve endothelial cells so they would stain with vital stains. All animals were treated throughout these experiments according to the "Principles of Laboratory Animal Care," formulated by the National Society for Medical Research, and according to the "Guide for the Care and Use of Laboratory Animals," prepared by the National Academy of Science and published by the National Institutes of Health (NIH Publication No. 80-23, revised 1978) .
Stent. The parallel wire stent consists of 10 or 12 stainless steel rods with a diameter of 0.20 or 0.25 mm, respec-American Heart Journal tively (Fig. 1 ). The ends of these rods are welded by laser diameter of the stent has an inverse nearly linear relation light in a zig-zag pattern, resulting in a cylinder shape. to its radial force (Fig. 2) . The stent diameter was intended Length of the applied stents varies between 8 and 12 mm, to be approximately 0.5 mm larger than the recipient vescorresponding to a diameter of 3.0 to 4.5 mm, respectively sellop l2 to avoid migration of the stent or overstretching of ( Table I ). The number of rods and the expansion ratios are the vessel wall. The size of the guiding catheter was used also presented in Table I . Depending on the diameter of the to estimate vessel size. stent, the expansion ratios vary between 5.0 and 7.4. The Delivery system.
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(Medtronic
Inc.) was used for implantation of the stent. This system consists of a polyethylene inner and Teflon outer catheter ( Fig. 1, A) . A marker is positioned at the distal tip of the inner catheter providing visualization. Before implantation, the stent is gently compressed and loaded at the distal end of a 4.2F or 4.9F outer catheter. The loaded outer catheter is introduced in a guiding catheter and the system is moved to a previously determined site in the coronary artery over a 0.014 inch guide wire. The inner catheter is advanced until it abuts against the stent. By withdrawing the outer catheter while the inner catheter is held stationary, the stent is freed and allowed to expand at the original location ( Fig. 1, B) .
Pathology. Coronary artery specimens with stents were dissected for macroscopic and microscopic investigation. The vessels were prepared according to the method of Palmaz et al.lg In summary, the stented coronary artery segments were fixed in glutaraldehyde (2.5 % ) and embedded in methyl-methacrylate (K-plast, Medem, Giessen, Germany). Cross sections of 1.2 mm thickness were obtained with a diamond saw. The metal pieces of the stent were removed from the methyl-methacrylate slices with a sharp needle under visual control using a dissecting microscope.
Tissue specimens were sectioned at 2 pm thickness and the methyl-methacrylate was dissolved in chloroform. The tissue was stained with hematoxylin-eosin stain and elastin van Gieson stain.
Apart from macroscopic and microscopic examination, the diameter of the stents in relation to the vessel diameter was measured. Further, the thickness of the neointimal layer was measured at the midportion of the stent. From this slice a picture was taken, in which a line was drawn from the middle of the rod to the middle of the vessel. This line intersected the surface of the rod and the luminal surface of the neointima above the rod. The distance between these two points was the thickness of the neointimal layer.
RESULTS
Implantation.
Sixty-two stents were i&planted in normal coronary arteries of 31 pigs. Coronary distribution and diameter of the stents, curvatures, and side branches of the vessels, the presence or absence of complications during implantation, and the follow-up are presented in Table II tery, eight in the circumflex artery, and 40 in the right coronary artery. Total durations of implants were: 14 stents: < 24 hours; 10 stents: 1 week; 24 stents: 3 to 4 weeks; 11 stents: 8 to 10 weeks; and three stents: 6 months. Five stents were released in side branches. In one pig a stent was positioned in a rather small acute marginal branch of the right coronary artery; in another it was released in a small marginal branch of the circumflex artery. The third stent was freed in a small intermediate branch and two stents were brought into a small posterodescending branch of the right coronary artery. These mistakes can be attributed to the limited visibility of the stent and to the low resolution of the x-ray system available. Furthermore, contrast injection through the delivery system is only possible by a motor-powered injector, which was also not available. Release of the stent was complicated in two cases when the stent was hooked at the guide wire. The wire probably was pinched'into the sharp angle of two rods. Advancement of the inner catheter through the released stent into the coronary artery proved to be the solution to this problem. All stents expanded reliably. Since the stent used is rather short in length (5 12 mm) and most balloons are 20 to 25 mm in length, three tandem placements were attempted to simulate human application. These implantations were uneventful. During the implantation procedures no rupture of the vessel, acute migration of the stent, or abrupt thrombosis of the artery were observed. Immediately afterwards, all vessels were patent, although slow flow was visible in the small acute marginal branch of the right coronary artery referred to above. Directly after implantation angiographically determined spasm was noted in six pigs, which disappeared after injecting intracoronary nitroglycerin in five of them. The remaining pig showed persistent ST segment elevation and subsequently died. One pig had intractable ventricular fibrillation during closure of the wound. Two other pigs died within a few hours after implantation: one pig due to hyperthermia, in the other animal a myocardial infarction and a nonocclusive thrombus were observed at autopsy. Follow-up. Recovery was uneventful in the 27 animals (56 stents) that survived the first 24 hours. One pig (three stents) developed intractable ventricular fibrillation during intubation prior to fluoroscopy 1 day after implantation. Another pig (two stents) died at 1 week after a bleeding complication due to punc- ture of the jugular vein. Repeat angiography at 1 week revealed that all but two of the stented arteries, including the side branches, in the remaining 25 pigs were fully patent. The small acute marginal branch, in which the oversized 3.5 mm stent was introduced, had occluded. This pig died shortly after the second angiography.
The posterodescending branch of the right coronary artery loaded with two stents had also occluded. Spontaneous migration out of the coronary arteries was observed with two stents for unknown reasons. One stent was found in a carotid artery; the location of the other stent could not be identified. Angiographically, the remaining stents were positioned at the initial site of implantation. Catheterization data at 3 and 8 weeks were comparable with data obtained 1 week after implantation. At 6 months one rather small stented intermediate branch had significantly narrowed.
Autopsy. As explained previously, seven pigs died prematurely. The other 24 pigs were put to death at the end of the experiment. Macroscopic examination of the diameter of the stented arteries was comparable with the diameter found during the last coronary angiography. Most stents had expanded rather symmetrically. The (maximal) diameter of the released stents was measured in their midsections. Diameter of the implanted stents was 3.1 mm (mean) compared with 3.8 mm (mean) of the uncompressed stents. The difference of 0.7 mm indicates that the clinical judgment of the degree of oversizing was reasonably accurate. The mean difference between minimal and maximal stent diameter was 16 % (range 2 % to 33 % ). Thrombus formation in the proximity of the stents was found in 3 of 24 sacrificed animals (two nonocelusive and one occlusive), while four of seven prematurely deceased animals had thrombi (two nonocelusive and two occlusive) (Table II) . Autopsy of the pig who died of hyperthermia and of the other pig dead within 24 hours due to spasm showed no aber- rations. In the pig that died because of ventricular fibrillation, macroscopic evidence of myocardial infarction was found in the presence of wide open arteries (Table II ). In total, in six sacrificed and three deceased animals macroscopic evidence for myocardial infarction was present; in six of these nine pigs intracoronary thrombi could be demonstrated (Table  II) . None of the side branches, observed during histology, had occluded.
Microscopy of the vessels, in which no macroscopic thrombi were seen, showed that immediately after implantation the endothelium had disappeared at the contact sites of the wires and the vessel wall. The media had not changed its architecture. Fibrin deposition was present around approximately half of the rods. One day after implantation the media thickness just below the contact sites had decreased and an imprint of the wire was visible in the media, with focal disruptions of the internal elastic lamina. No changes were seen in the remaining vessel wall. In between 24 hours and 1 week the spaces between the rods and the vessel wall were filled with a deposit that might be thrombotic material (Fig. 3, A) . At 1 week the imprints of the rods in the media were still present. At the luminal site the rods were covered by a loose layer of smooth muscle-like cells. This layer was capped with a single endothelium-like cell layer ( Fig. 3, B) . After 3 weeks the neointima was more dense and the struts were fully embedded in a neointimal layer. This tissue was also found between the struts in some but not in all vessels. Thickness of the neointimal layer was approximately 180 pm (Fig.  4) . The thickness of this layer was comparable at 3 to 4, 8 to 10, and at 26 weeks (Table III) . Probably due to oversizing, fibrous tissue and recanalization were seen in the small artery that was stented 6 months previously (Fig. 5 ). Hyperplasia could have been initiated by the disruption of the vessel wall itself. It might also have been due to reorganized thrombus, because subendothelial tissue was set free by the disruption that probably led to thrombus formation. Scanning electron microscopy demonstrates the complete coverage of the rods with endothelial-like cells (Fig. 6 ).
DISCUSSION
Intravascular devices like stents can prevent acute occlusion of dissected arteries.20 At present it is not clear whether the rate of restenosis can be diminished by stent implantation. 17, 18, 21 Several stents are under investigation.* Three types are presently used: the self-expanding, the balloon-expandable, and the *References 1, 7 to 1%. 14, 22, and Xi. thermal shape memory type, all of metal materials. Duprat et a1.12 introduced a zig-zag self-expanding stent (Gianturco stent) of five bends. This stent resembles the parallel wire stent used in our experiments. In the Gianturco stent,12 the wire is bent into a zig-zag pattern with the ends connected to form a cylinder. The Medtronic parallel-wire stent uses a similar expansion mechanism. However, the construction of this stent is different and consists of 10 or 12 separate rods, which are welded at the ends by laser light. This results in a device that can be downsized for coronary use. This is also reflected by the expansion ratios varying between 5 and 7, which is even better than the Palmaz-Schatz coronary stent that has a ratio of 4. In contrast to most other investigators who used dogs or rabbits, we implanted the stents in the coronary arteries of young pigs. The advantage of this animal is a better similarity to humans with respect to coronary artery size and clotting mechanism. We tested the stents in coronary arteries instead of in peripheral arteries to demonstrate the behavior of the stent in the most difficult environment: a moving contractile object in the absence of antithrombotic agents. Bonan et a1.22 reported that this self-expanding stent can be introduced into normal coronary arteries of dogs with relatively good accuracy. Clearly, its size must be carefully selected with respect to the diameter of the recipient vessel.lOT l2 In the present study, a small side branch was stented in five occasions (four vessels). Poor visibility due to the stent itself and due to the x-ray equipment contributed to misplacement. White et a1.27 have reported improved visibility with a new, tantalum flexible balloonexpandable stent (Wiktor stent).
Ratio of stent and recipient artery. The stent must exert sufficient pressure on the vessel wall to reestablish patency, but not too much to cause damage or rupture of the vessel. Duprat et a1.12 stated that the ratio of stent and recipient artery (SAR) should be >l.O and <1.2, which is supposed to be optimal to maintain an open vessel lumen. A SAR <l will result in migration of the stent. In our series, two stents migrated out of the coronary arteries. Measurement of the stent and recipient coronary artery showed that SARs were 1.40 and 1.75, respectively. Therefore, migration might be due to coronary spasm, vasomotor tone, recoil, or cyclic pulsation of the arterial segment. It indicates that migration of the presently used stents was not prevented by oversizing. Athero- December 1991 American Heart Journal sclerotic lesions in the coronary arteries of humans may make it less likely for the stent to be "squeezed" out of the vessel.
Fallone et a1.24 reported a logarithmic relation between diameter of the inserted stent and the radial force of the stent on the vessel wall. The parallel wire stent shows an inverse nearly linear relation between the diameter of the stent and the radial force (Fig. 2) . This behavior might be useful for accurate sizing of the stent.
A SAR > 1.2 would result in overstretching of the vascular wall and would lead to excessive trauma of the intima. Whether these observations also hold for other than the Gianturco stents is presently not known, although overstretching is associated with acute spasm and increased rates of immediate or delayed thrombosis and hyperplasia.12, 17, 18t 21 The findings from the present study indicate that when the stent was implanted in a small artery (oversizing), this usually resulted in severe trauma of the intimal wall: thrombotic occlusion usually was the result of the "mismatch" between the diameters of stent and vessel. In our experiments, excessive proliferation, however, was not observed.
Thrombosis.
The implantation
conditions were deliberately made difficult by withholding antithrombotic drugs except for heparin during the implantation procedure (no anticoagulant, dextran, or antiplatelet aggregation therapy was applied during or after the procedure). Nonocclusive thrombi were found only in four animals and an occlusive thrombus was found in three other pigs. In accordance with other animal studies, thrombus formation was only present in the early stages (the first 4 weeks) after implantation.'7v l8 The surprisingly low incidence of thrombosis contrasts with human experience where, in the absence of anticoagulant and antiplatelet aggregation drugs, thrombus formation, resulting in (sub)acute occlusion, is a common finding.l, l3 This might be explained by interspecies differences in thrombogenicity, the difference between the normal swine coronary arteries and the atherosclerotic vessels of patients, or the absence of a PTCA procedure. Whether or not the design of a stent is related to thrombogenicity is unclear. Spasm. Our findings indicate that the occurrence of spasm in coronary arteries of healthy pigs affected the outcome of these experiments. Any foreign body within the arterial lumen can enhance vasomotor tone. Apart from the two pigs showing stent migration, angiographic and electrocardiographic proof of spasm was observed in six other animals. Although coronary spasm can also occur in man, it is far less frequent than its occurrence in our study. After stent implantation spasm has been described in only a few human cases.18, 25 In the present study, intractable spasm in the early phase after stent implantation was no longer observed after pretreatment with intracoronary nitroglycerin before implantation of the stent.
Possible advantages of the parallel wire stent. In the animals killed at 3 weeks, complete coverage of the 0.20 and 0.25 mm rods with a thin neointimal layer was the usual finding. Bonan et a1.,22 using the same stent in canines, reported similar results. This is also in accordance with the findings of other investigators, showing that coverage of the stent surface depends on the thickness of the metal rods. Wright et a1.26 reported only 30 "2, covering of a 0.46 mm wire after 1 month, while Sigwart et a1.l demonstrated complete coverage of the 0.09 mm filaments of their stents within 3 weeks.
Another possible advantage of the parallel wire stent in comparison with some other stents is the rather low coverage rate of approximately 25 '0 of the surface of the recipient vessel wall (Table I) . This favors not only fast neointimal coverage, but might also minimize endothelial damage. Furthermore, it is likely that side branches will remain open more easily. In the present study, none of the side branches covered by a stent occluded during the observation period. It is still unknown whether the low coverage rate of the stent will also result in a lower restenosis rate in humans, as suggested by Schatz.18 Finally, following implantation, PTCA is unnecessary because of the self-expanding nature of the stent. From autopsy data it appears that the stent gradually expands in time into the coronary artery wall.
Possible disadvantages of the parallel wire stent. The parallel wire stent is a rigid device in the longitudinal direction. Therefore this stent is probably most useful in the more straight peripheral arteries. It might be difficult to accommodate rigid stents in curved target lesions or tortuous vessels. Schatzis suggested the use of multiple short stents in curvatures.18 He also stated that multiple stent implantation results in a higher incidence of thrombosis. In our experiments, stents in tandem were implanted in three vessels, demonstrating the feasibility of this approach. In one of these three in tandem stents thrombus formation was observed. No perforation was found, although several stents were located in mild or moderate curvatures. However, the ends of some struts were found to be in the adventitial layer of the vessels. The rather limited length of the coronary stent (8 to 12 mm) is another disadvantage. However, it does not seem to be a major practical problem, while implantation can be performed rapidly. Multiple stents can be implanted in sequence over larger curved segments within a reasonable time frame. While length and diameter of the parallel wire stent are related, length of this stent will be longer in the larger peripheral arteries.
In conclusion, this investigation indicates that coronary implantation of this stent was easy. Compared with human studies, in the present animal experiments thrombus formation was rather uncommon despite the absence of chronic anticoagulant and antiplatelet aggregation therapy. This self-expanding parallel wire stent might represent a valuable adjunct to the presently available stents. However, since this study reports only the response of stenting in normal swine coronary arteries, further evaluation is required.
